Five Big Legal Stories From 2022
Teva, Sandoz And Viatris All Featured Prominently In 2022’s Stand Out Cases
Generics Bulletin looks back at a selection of the most significant legal stories from 2022, including a major victory in the UK on the Eliquis blood thinner giant and continued action on generic label carve outs, which has the potential to reverberate through the US industry.
